343 related articles for article (PubMed ID: 17322496)
1. Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy.
Rizzo M; Trepp R; Berneis K; Christ ER
Eur J Endocrinol; 2007 Mar; 156(3):361-7. PubMed ID: 17322496
[TBL] [Abstract][Full Text] [Related]
2. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy.
Monson JP; Jönsson P; Koltowska-Häggström M; Kourides I
Clin Endocrinol (Oxf); 2007 Oct; 67(4):623-8. PubMed ID: 17581260
[TBL] [Abstract][Full Text] [Related]
4. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.
Abs R; Feldt-Rasmussen U; Mattsson AF; Monson JP; Bengtsson BA; Góth MI; Wilton P; Koltowska-Häggström M
Eur J Endocrinol; 2006 Jul; 155(1):79-90. PubMed ID: 16793953
[TBL] [Abstract][Full Text] [Related]
5. Low density lipoprotein particle size in hypopituitary adults receiving conventional hormone replacement therapy.
O'Neal D; Hew FL; Sikaris K; Ward G; Alford F; Best JD
J Clin Endocrinol Metab; 1996 Jul; 81(7):2448-54. PubMed ID: 8675559
[TBL] [Abstract][Full Text] [Related]
6. Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis.
Rizzo M; Spinas GA; Cesur M; Ozbalkan Z; Rini GB; Berneis K
Atherosclerosis; 2009 Dec; 207(2):502-6. PubMed ID: 19643412
[TBL] [Abstract][Full Text] [Related]
7. Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes.
Rizzo M; Berneis K; Altinova AE; Toruner FB; Akturk M; Ayvaz G; Rini GB; Spinas GA; Arslan M
Diabet Med; 2008 Dec; 25(12):1406-11. PubMed ID: 19046238
[TBL] [Abstract][Full Text] [Related]
8. Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome.
Berneis K; Rizzo M; Lazzarini V; Fruzzetti F; Carmina E
J Clin Endocrinol Metab; 2007 Jan; 92(1):186-9. PubMed ID: 17062762
[TBL] [Abstract][Full Text] [Related]
9. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone and the risk of atherosclerosis in growth hormone-deficient children.
Binay C; Simsek E; Yıldırım A; Kosger P; Demiral M; Kılıç Z
Growth Horm IGF Res; 2015 Dec; 25(6):294-7. PubMed ID: 26296621
[TBL] [Abstract][Full Text] [Related]
11. Metabolic effects of growth hormone (GH) replacement in children and adolescents with severe isolated GH deficiency due to a GHRH receptor mutation.
Gleeson H; Barreto ES; Salvatori R; Costa L; Oliveira CR; Pereira RM; Clayton P; Aguiar-Oliveira MH
Clin Endocrinol (Oxf); 2007 Apr; 66(4):466-74. PubMed ID: 17371461
[TBL] [Abstract][Full Text] [Related]
12. Effects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects.
Kearney T; de Gallegos CN; Proudler A; Parker K; Anayaoku V; Bannister P; Venkatesan S; Johnston DG
Metabolism; 2003 Jan; 52(1):50-9. PubMed ID: 12524662
[TBL] [Abstract][Full Text] [Related]
13. Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.
al-Shoumer KA; Cox KH; Hughes CL; Richmond W; Johnston DG
J Clin Endocrinol Metab; 1997 Aug; 82(8):2653-9. PubMed ID: 9253349
[TBL] [Abstract][Full Text] [Related]
14. The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy.
O'Neal DN; Hew FL; Best JD; Alford F
Growth Horm IGF Res; 1999 Jun; 9(3):165-73. PubMed ID: 10502452
[TBL] [Abstract][Full Text] [Related]
15. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
[TBL] [Abstract][Full Text] [Related]
16. Effects of GH on lipid peroxidation and neutrophil superoxide anion-generating capacity in hypopituitary adults with GH deficiency.
Smith JC; Lang D; McEneny J; Evans LM; Scanlon MF; Young I; Davies J
Clin Endocrinol (Oxf); 2002 Apr; 56(4):449-55. PubMed ID: 11966737
[TBL] [Abstract][Full Text] [Related]
17. Post-prandial alterations in LDL size and subclasses in patients with growth hormone deficiency.
Rizzo M; Trepp R; Berneis K; Christ ER
Growth Horm IGF Res; 2008 Jun; 18(3):264-6. PubMed ID: 18054508
[TBL] [Abstract][Full Text] [Related]
18. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
[TBL] [Abstract][Full Text] [Related]
19. Hypopituitarsim is associated with triglyceride enrichment of very low-density lipoprotein.
Kearney T; Navas de Gallegos C; Chrisoulidou A; Gray R; Bannister P; Venkatesan S; Johnston DG
J Clin Endocrinol Metab; 2001 Aug; 86(8):3900-6. PubMed ID: 11502830
[TBL] [Abstract][Full Text] [Related]
20. Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease.
Rizzo M; Pernice V; Frasheri A; Berneis K
Atherosclerosis; 2008 Mar; 197(1):237-41. PubMed ID: 17485096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
